Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug — Live Feedhttps://www.live-feeds.com/feed/former-eli-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drugContinuously updated, source-cited coverage. Former Eli Lilly sales rep sues over alleged retaliation for Mounjaro marketing complaintshttps://www.live-feeds.com/feed/former-eli-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drughttps://www.live-feeds.com/feed/former-eli-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drug#u201893Sun, 15 Nov 2026 06:48:34 +0000A former Eli Lilly sales representative has filed a retaliation lawsuit alleging she was fired after objecting to the off-label promotion of Mounjaro for weight loss. The drug is approved for type 2 diabetes but has seen widespread off-label use for obesity. Multiple outlets report the suit accuses Lilly of retaliatory termination after the representative raised concerns about marketing practices that encouraged promotion beyond the FDA-approved indication. The case highlights ongoing scrutiny of how GLP-1 agonists are marketed amid soaring demand for weight-loss treatments.Why it mattersMounj